Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study

被引：0
作者：
A Roy
D Cunningham
R Hawkins
H Sörbye
A Adenis
J-R Barcelo
G Lopez-Vivanco
G Adler
J-L Canon
F Lofts
C Castanon
E Fonseca
O Rixe
J Aparicio
J Cassinello
M Nicolson
M Mousseau
A Schalhorn
L D'Hondt
J Kerger
D K Hossfeld
C Garcia Giron
R Rodriguez
P Schoffski
J-L Misset
机构：
[1] Royal Marsden Hospital,Department of Medicine
[2] University of Manchester,Department of Medical Oncology
[3] Haukeland University Hospital,Department of Medical Oncology
[4] Centre Oscar Lambret,Department of Gastrointestinal Oncology
[5] Hospital de Cruces Osakidetza,Department of Oncology
[6] University of Ulm,Department of Medicine
[7] Oncologie Médicale,Department of Oncology
[8] Grand Hopital de Charleroi,Department of Medical Oncology
[9] St George’s Hospital NHS Trust,Department of Medical Oncology
[10] Hospital Clinico de Salamanca,Department of Medical Oncology
[11] Hospital Universitario Paseo de San Vicente,Department of Medical Oncology
[12] Salpêtrière Hospital,Department of Medical Oncology
[13] Hospital Universitario La Fe,Department of Oncology
[14] Hospital General Universitario de Guadalajara,Department of Oncology and Haematology
[15] Aberdeen Royal Infirmary,Department of Oncology
[16] University Hospital,Haematology
[17] Klinikum der Universität München Grosshadern,Department of Medical Oncology
[18] Chu Mont Godinne,Department of Medical Oncology
[19] Medical University Clinic,Department of Medical Oncology
[20] Hospital General Yagüe,undefined
[21] Complejo Hospitalario de Orense,undefined
[22] Leuven Cancer Institute,undefined
[23] University Hospitals,undefined
[24] Médicale Hôpital St Louis,undefined
[25] 1 av. Claude Vellefaux,undefined
[26] Paris 75010,undefined
[27] France,undefined
来源：
British Journal of Cancer | 2012年 / 107卷
关键词：
oesophago-gastric cancer; docetaxel; irinotecan; 5-fluorouracil;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：435 / 441
页数：6
相关论文
共 315 条
  • [1] Ajani JA(2005)Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma J Clin Oncol 23 5660-5667
  • [2] Fodor MB(2004)Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma Ann Oncol 15 64-69
  • [3] Tjulandin SA(2010)Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet 376 687-697
  • [4] Moiseyenko VM(2009)Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study Lancet Oncol 10 1063-1069
  • [5] Chao Y(2002)Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: results of a phase II study Gastric Cancer 5 142-147
  • [6] Cabral Filho S(2008)Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med 358 36-46
  • [7] Majlis A(2005)Randomized phase 3 trial of irinotecan (CPT-11)+5FU/folinic acid (FA) vs CDDP+5FU in 1st-line advanced gastric cancer patients ASCO Meeting Abstracts 23 4003-656
  • [8] Assadourian S(2006)Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group Ann Oncol 17 652-1151
  • [9] Van Cutsem E(2011)Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer Eur J Cancer 47 1146-123
  • [10] Assersohn L(2002)A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia Int J Gastrointest Cancer 32 115-90
12345678910